Biomarkers
Biomarker testing you can trust
We provide comprehensive biomarker solutions designed to support every stage of your research journey.
Comprehensive experience
With numerous biomarkers available across multiple platforms, species, and matrices, our services are designed to meet the diverse needs of your therapeutic area.
Explore our biomarker menu to learn more about our extensive off-the-shelf assay portfolio and the scientific expertise that supports biomarker programs from discovery through clinical development.
End-to-end biomarker services
Whether you're conducting exploratory research or preparing for regulatory submission, our team offers unmatched expertise in:
-
Biomarker assay development
-
Assay validation
-
Custom and fit-for-purpose solutions
We tailor our approach to your study’s goals, ensuring accuracy, compliance, and scientific integrity.
Custom biomarker assay development
Need a sensitive, specific assay for a novel biomarker? Our integrated biomarker solutions support:
-
Development of novel protein biomarker assays
-
Use of commercially available kits for cost-effective, scalable solutions
-
Exploratory biomarker services for early-stage research
Validated biomarker services
Regulatory success depends on robust, validated data. We offer:
-
Full GxP compliance
-
Fit-for-purpose validation strategies
-
Single- and multiplex assay capabilities
-
Cross-validation and consultation services
Our team ensures your biomarker data meets the highest standards for regulatory submission.
Advanced platforms for biomarker assessment
Our laboratories are equipped with cutting-edge instrumentation to support flexible, scalable biomarker analysis. Whether you're in the exploratory or validation phase, we help you choose the right platform for your needs.
Blog article
Unlocking Precision: The Power of Ligand Binding Assays in Clinical Trials
Learn how ligand binding assays (LBAs) provide precise, compliant analysis for biologics in clinical trials, supported by Eurofins’ expert bioanalytical services.
Let’s build what’s next – together
